Related by context. All words. (Click for frequent words.) 65 antisense oligonucleotide 63 thrombin receptor 63 PEG IFN 62 multikinase inhibitor 62 Cytochrome P# 62 PI3K inhibitor 62 Kinase Inhibitor 61 antisense inhibitor 61 GW# [003] 61 beta1 61 PKC# 61 beta 1a 61 HDACi 61 mediated inhibition 60 receptor blocker 60 polymerase inhibitor 60 proteasome inhibitor 60 selective agonist 60 Enzastaurin 60 Fenretinide 60 receptor tyrosine kinase inhibitor 60 immunoconjugate 60 1beta 60 Factor VIIa 60 TNF α 60 β2 60 Antiviral Therapy 60 colon carcinoma 60 chemokine receptor 59 abacavir Ziagen 59 Gleevec resistant 59 histone deacetylase inhibitor 59 Pharmacokinetics PK 59 CCR5 antagonist 59 muscarinic antagonist 59 Myelodysplastic Syndrome MDS 59 liposomal formulation 59 thyroid hormone receptor 59 Androgen Receptor 59 gamma secretase inhibitor 59 Fingolimod 59 Kahalalide F 59 receptor antagonism 59 elvitegravir 59 Tumor Necrosis Factor 59 geldanamycin 58 humanized monoclonal 58 hydroxamic acid 58 JAK2 inhibitor 58 receptor antagonists 58 receptor inhibitor 58 Teriflunomide 58 peptide CGRP 58 orally dosed 58 gene polymorphism 58 DNA intercalator 58 pertussis toxin 58 aurora kinase 58 BMS # 58 potently inhibits 58 pan HDAC inhibitor 58 Aurora Kinase 58 HSP# inhibitor 58 ribonuclease 58 Recombinant Human 58 PDE4 inhibitor 57 Liposomal 57 FLT3 57 antisense inhibitors 57 mesylate 57 glycogen synthase kinase 57 thalidomide Thalomid 57 annexin 57 Proteasome 57 adenoviral 57 Multiple Myeloma MM 57 Fc fusion protein 57 non nucleoside 57 Myelofibrosis 57 nucleoside analog 57 immunotherapeutic vaccine 57 gefitinib Iressa 57 BIM #A# 57 glutamine synthetase 57 Protein Kinase 57 small molecule tyrosine 57 selective antagonist 57 neurokinin 57 IFN β 57 AT1R 57 #β estradiol 57 inverse agonist 57 PLA2 57 oral treprostinil 57 histone acetyltransferase 57 androgen receptor AR 57 irreversible inhibitor 57 NS4A antagonist 57 IL 1ß 56 soluble receptor 56 null mice 56 syngeneic 56 Protein Kinase C 56 isoenzyme 56 ND# [002] 56 cytidine 56 adrenoceptor 56 mineralocorticoid receptor 56 BCR ABL1 56 estradiol E2 56 Oncogenic 56 Rap1 56 HLA DR4 56 Catenin 56 ABCB1 56 Protease 56 transduced 56 Polymorphism 56 cyclic peptide 56 RhuDex R 56 PKC inhibitor 56 antitrypsin 56 BMP2 56 reversible inhibitor 56 Ziprasidone 56 hepatoma 56 receptor antagonist 56 muscarinic 56 RhuDex ® 56 thymidine kinase 56 MEFs 56 Bosutinib 56 Matrix metalloproteinase 56 Granulocyte Colony Stimulating Factor 56 adrenergic receptor agonist 56 HepDirect prodrug 56 Myeloid 56 p# MAPK 56 virus HCV 56 metastatic malignant 56 receptor blockers 56 monoclonal antibody mAb 56 embryonal carcinoma 56 huN# DM1 56 PI3K/mTOR 56 splenocytes 56 mimetic peptide 56 MTP inhibitor 56 Shc 55 Orally administered 55 erythropoietic 55 LPS induced 55 histone deacetylase HDAC inhibitor 55 beta3 55 Mucosal 55 IFN α 55 glycopeptide 55 Receptor Antagonists 55 HLA A2 55 protein tyrosine 55 intranasal formulation 55 monoclonal anti 55 Cytochrome 55 PPARgamma 55 LB# [003] 55 Pharmacokinetic studies 55 binds selectively 55 ERK1 2 55 Topoisomerase II 55 uricase 55 Flt3 55 serine protease inhibitor 55 P2Y 55 Potent Inhibitor 55 TLR9 agonist 55 Topoisomerase 55 receptor monoclonal antibody 55 Pathway Inhibitor 55 calcitonin gene related 55 somatostatin analog 55 Darusentan 55 DEB# 55 Prodrug 55 natriuretic peptide 55 nucleotide analog 55 KN# [001] 55 selective inhibitor 55 GHRH 55 mediated phosphorylation 55 induced apoptosis 55 selectively inhibits 55 RhuDex 55 receptor modulators 55 aurora kinase inhibitor 55 kinase pathway 55 topoisomerase II inhibitor 55 Macrophage 55 P2X 55 prucalopride 55 ABL1 55 monocyte chemotactic protein 55 glycosyltransferase 55 beta subunit 55 SGLT 55 plasmid encoding 55 BEZ# 55 Galectin 55 Imatinib mesylate 55 PEG Interferon 55 Monoclonal antibody 55 C#BL 6 mice 55 anti CD3 55 recurrent glioblastoma multiforme 55 Akt activation 55 induced phosphorylation 55 ARG# 55 Maribavir 55 potent inducer 55 cathepsin K inhibitor 55 selective adenosine 55 Janus Kinase 54 Temsirolimus 54 E3 ligase 54 Reductase 54 tissue transglutaminase 54 1alpha 54 murine monoclonal antibody 54 Anavex #-# 54 antimicrobial peptide 54 scavenger receptor 54 Preclinical studies indicate 54 Î ² 54 Tubulin 54 decarboxylase 54 Teysuno 54 fludarabine cyclophosphamide 54 Monocyte 54 Ixabepilone 54 Angiotensin Converting Enzyme 54 volociximab 54 Polymorphisms 54 EGFP 54 dose dependently 54 cotransporter 54 Progressive Multifocal Leukoencephalopathy 54 acute intermittent porphyria 54 Enkephalin 54 prolyl 54 rhMBL 54 glioma cells 54 dihydrofolate reductase 54 cyclin dependent kinase inhibitor 54 COL#A# 54 Hsp 54 IL6 54 Ectopic expression 54 Glycosylation 54 bile acid sequestrant 54 cell adhesion molecule 54 Epirubicin 54 retinoic acid receptor 54 subcutaneous immunoglobulin 54 antiproliferative effects 54 demonstrated antitumor activity 54 Cardiotoxicity 54 CC genotype 54 VEGF receptor 54 serpin 54 VEGF inhibitor 54 downregulates 54 cathepsin B 54 Polymerase 54 Posiphen 54 rFSH 54 CsA 54 PI3K Akt 54 azacytidine 54 Kevetrin ™ 54 Pgp 54 CCR1 54 bifunctional 54 Plasmid DNA 54 pathway inhibitor 54 urokinase plasminogen activator 54 cyclophosphamide methotrexate 54 labetuzumab 54 Yondelis ® 54 peptide fragment 54 Abstract Number 54 M1 muscarinic 54 potently inhibit 54 pentamidine 54 CCR5 inhibitor 54 MAGE A3 ASCI 54 humanized monoclonal antibody 54 IL #E 54 deoxy 54 Annexin V 54 cyclooxygenase COX 54 RhuDex TM 54 long acting muscarinic 54 HepG2 cells 54 Vinorelbine 54 DFMO 54 lipopeptide 54 CTLA4 54 Protease Inhibitors 54 Telintra 54 Vidaza azacitidine 54 selective inhibition 54 PTK# 53 administered subcutaneously 53 histone deacetylase inhibitors 53 vidofludimus 53 siRNA therapeutic 53 transiently transfected 53 Janus kinase 53 EGFR HER2 53 replicase 53 Vascular Disrupting Agent 53 adrenergic receptor 53 renin inhibitor 53 muscarinic receptor 53 topically administered 53 AtuRNAi 53 aminopeptidase 53 acetyltransferase 53 IL 1β 53 chimeric monoclonal antibody 53 Receptor Agonist 53 Cannabinoid 53 mineralocorticoid 53 aminotransferase 53 bradykinin 53 Cytotoxic 53 Cardiac Troponin 53 potently inhibited 53 RH1 53 interleukin IL 53 demyelinating 53 highly selective inhibitor 53 NM# [003] 53 activin 53 bone marrow stromal cells 53 peptidase 53 epithelial sodium 53 unconjugated 53 N acetyl 53 mice overexpressing 53 idebenone 53 Cyclosporin 53 adenylate cyclase 53 ATL/TV# 53 triciribine phosphate monohydrate 53 CCL# 53 Camptothecin 53 photoprotective drug 53 hepatic fibrosis 53 demethylating agent 53 Cathepsin S 53 P selectin 53 Natalizumab 53 Upregulation 53 gamma glutamyl 53 Phase IIA 53 Myelodysplastic Syndrome 53 inhibitory effects 53 stably transfected 53 cholesteryl ester transfer 53 constitutively active 53 RNA antagonists 53 VSV G 53 selective estrogen receptor modulator 53 antiproliferative activity 53 Secretase 53 immunomodulatory therapy 53 peptide receptor 53 vWF 53 Adrenergic 53 SGLT2 inhibitors 53 edifoligide 53 relapsing multiple sclerosis 53 isoform selective 53 mononuclear 53 bone morphogenic protein 53 Histone 53 JEV 53 vinca alkaloid 53 MEK1 53 Oligonucleotide 53 IAP inhibitor 53 ibritumomab tiuxetan 53 targeted antifolate 53 PPMO 53 Hsp# Inhibitor 53 vascular disrupting agents 53 substrate specificity 53 TNFalpha 53 β1 53 ESR1 53 Rindopepimut 53 phosphoprotein 53 antiapoptotic 53 cortisol receptor 53 Decitabine 53 poly ADP ribose polymerase 53 plasminogen activator 53 Campath alemtuzumab 53 PARP inhibitor 53 5HT 53 Hcy 53 2 microglobulin 53 NN# [001] 53 vasodilatory 53 activating mutation 53 β actin 53 diagnostic biomarker 53 1α 53 colorectal liver metastases 53 novel prodrug 53 CYP #D# 53 Tumor Angiogenesis 53 Syk 53 Tie2 53 phosphorylase 53 VEGFR1 53 Kinoid 53 peroxidase 53 monocytes macrophages 53 tyrosine kinase receptor 53 cytochrome P# 53 Interferon alfa 53 protein tyrosine phosphatase 1B 53 NQO1 53 selectively inhibiting 53 humanised monoclonal antibody 53 methyltransferase 53 sodium glucose cotransporter 53 ERalpha 53 PEGylated 53 urate oxidase 52 kDa protein 52 regulated kinase 52 hydrolase 52 Hematopoietic 52 5alpha reductase 52 lysophosphatidic acid 52 parthenolide 52 Double Blind Randomized 52 fluoropyrimidine 52 TNFα 52 cefotaxime 52 Anticalin ® 52 dorsal root ganglion 52 antiangiogenic agent 52 T2DM 52 peginterferon alpha 52 IIa trials 52 VKORC1 52 SSc 52 Idiopathic Pulmonary Fibrosis 52 Rho kinase 52 maytansinoid 52 Degarelix 52 Systemic Delivery 52 Ganciclovir 52 Bruton tyrosine kinase Btk 52 beta lactamases 52 folate receptor 52 selectively binds 52 cytotoxicity assays 52 db db mice 52 protein tyrosine kinase 52 phosphatidylinositol 3 52 inducible nitric oxide synthase 52 AMPK activators 52 tumor antigen 52 NIDDM 52 Dysregulation 52 FVIIa 52 Fibroblast 52 SGLT2 inhibitor 52 novel immunotherapeutic 52 Leukotriene 52 prostanoid 52 adult mesenchymal stem 52 Notch receptor 52 dimeric 52 HoFH 52 radiolabeled 52 methionine aminopeptidase 52 neuroregenerative 52 cytotoxic T lymphocyte 52 Cathepsin B 52 Alkaline Phosphatase 52 Files IND 52 selective agonists 52 nicotinic acetylcholine receptor 52 CCL2 52 AmpliChip 52 Daclizumab 52 Monoclonal 52 Fibroblast Growth Factor Receptor 52 Dehydrogenase 52 Belerofon 52 dependent protein kinase 52 TIMP 1 52 PAOD 52 Protein kinase 52 bispecific 52 Angiogenic 52 enzyme cytochrome 52 phorbol 52 heme oxygenase 1 52 Fibroblast Growth Factor 52 lung fibrosis 52 siRNAs targeting 52 Aromatase 52 TLR2 52 DGAT1 52 IL 1beta 52 stem cell mobilizer 52 small molecule activators 52 selectively inhibited 52 Raf kinase 52 PEGylated interferon beta 1a 52 dasatinib Sprycel 52 thermosensitive 52 prostate cancer CaP 52 SOCS3 52 FGFR3 52 Immunostimulatory 52 outlicensed 52 Elevated serum 52 Annexin 52 lipoxygenase 52 leukocyte adhesion 52 reverse transcriptase inhibitors 52 ARC# [001] 52 patientswith 52 cyclic nucleotide 52 GlcNAc 52 adrenoceptor agonist 52 Interferon beta 52 Rab5 52 Central Venous Catheter 52 alpha agonists 52 interferon IFN 52 Epoetin 52 PI3 kinase inhibitor 52 Recombinant 52 acyltransferase 52 phospholipase D 52 lumiliximab 52 KSP inhibitor 52 Helixate R 52 transgenic rats 52 TIMP 52 converting enzyme 52 TGF ß 52 HGF 52 costimulation 52 deoxyglucose 52 interferon beta 52 hypoxia activated prodrug 52 reductase 52 MELAS 52 catechol O methyltransferase 51 cyclase 51 phosphoinositide 51 monocytic 51 tkRNAi 51 transferase 51 autoantigen 51 pDC 51 L alanine 51 RRM1 51 Tumor necrosis factor 51 tipifarnib 51 Neupogen ® 51 Arranon 51 3 kinase PI3K 51 dnaJP1 51 pegylated recombinant 51 PI3 kinase 51 Nicotinic 51 EphB4 51 Neutrophil 51 microsomal 51 Curaxin 51 papillary thyroid carcinoma 51 MMP2 51 diphosphate 51 thymidylate synthase TS 51 Analogs 51 carboxypeptidase 51 anaphase promoting complex 51 CRAC channel 51 cis retinoic acid 51 Neurol 51 SR# [004] 51 Valproic acid 51 CD# CD# 51 ANTEGREN 51 induced cytotoxicity 51 ErbB2 positive 51 matrix metalloproteinases MMPs 51 IFN γ 51 teriflunomide 51 RAS mutations 51 receptor blockers ARBs 51 aminolevulinic acid 51 TNFa 51 ENaC 51 MYBPC3 51 CXCR4 receptor 51 phosphatase 51 defibrotide 51 Methionine 51 histamine dihydrochloride 51 vascular disrupting agent 51 benzimidazole 51 #beta 51 TGF alpha 51 GlycoPEGylated 51 hematopoietic progenitor cells 51 LRAT 51 neuroprotective effects 51 glatiramer acetate GA 51 boosted atazanavir 51 delta selective PI3K 51 VMAT2 51 immunomodulating agents 51 P#Y# [002] 51 Nav#.# 51 atrial natriuretic peptide 51 fluticasone propionate FP 51 histone deacetylase 51 mTOR inhibitors 51 generation purine nucleoside 51 UDCA 51 nucleolar 51 calcitriol 51 Hepatotoxicity 51 Unstable Angina 51 bFGF 51 GCSF 51 NK1 51 cytokeratin 51 plasma renin activity 51 biotinylated 51 BCL2 51 SIR Spheres 51 olmesartan 51 antifibrotic 51 Alemtuzumab 51 Wiskott Aldrich syndrome 51 KSP inhibitors 51 Peyer patches 51 #mg/#mg 51 HIV reverse transcriptase 51 CZP 51 Antithrombin 51 Reverse Cholesterol Transport 51 Diazyme 51 thymoma 51 Actinic Keratosis 51 adduct 51 TransMID 51 PSN# [001] 51 matrix metalloproteases 51 cyclooxygenase 2 51 DNA glycosylase 51 tocilizumab 51 Prognostic significance 51 NS3 protease 51 Iluvien TM 51 hypomethylating agent 51 galectin 51 insulin sensitizing 51 synthetic siRNA 51 NKG2D 51 BPS IC 51 adrenergic agonists 51 c KIT 51 FKBP# 51 cytokine receptor 51 MDR1 51 KLF4 51 Angioedema 51 inhibitor ARRY 51 phosphorylates 51 IGF1R 51 EP4 51 NF kappaB activation 51 bone marrow progenitor cells 51 acute promyelocytic leukemia 51 antitumoral 51 IL2 51 neurological manifestations 51 ABCG1 51 afamelanotide 51 PF # [002] 51 Maxy G# 51 microtubule inhibitor 51 c myc 51 mitogen activated ERK kinase 51 5 hydroxytryptamine 51 polyamine 51 piperacillin tazobactam 51 adalimumab Humira 51 myeloproliferative disorders 51 novel orally bioavailable 51 ERK signaling 51 ribosomal protein 51 NS5B 51 adenosine A2A 51 beta actin 51 reflux esophagitis 51 lymphoproliferative disorders 51 lyase 51 Kantarjian 51 enzymatically active 51 rhITF 51 glutamyl 51 experimental autoimmune encephalomyelitis 51 Figure S4 51 liver histology 50 NS3 50 Bosentan 50 ADPKD 50 Apolipoprotein 50 Calcineurin 50 #ß 50 TGF β 50 advanced neuroendocrine tumors 50 Acute Coronary Syndromes ACS 50 downregulation 50 Pharmacologic 50 Collategene 50 dipeptide 50 metalloprotease 50 microsomes 50 reteplase 50 elastase 50 MVA HPV IL2 50 guanylyl cyclase 50 PrevOnco 50 Tissue Factor 50 CALGB # [002] 50 humanised antibody 50 Hepatic Encephalopathy 50 ^ sup ^ 50 medullary thyroid carcinoma 50 degranulation 50 poloxamer 50 pmol 50 S#P# 50 Tyrosine Kinase Inhibitors 50 Photodynamic 50 glucokinase 50 stage IIIB 50 Epothilone 50 5 HT2A serotonin 50 isomerase 50 cannabinoid receptor 50 pro angiogenic 50 Systemic Sclerosis 50 luciferase reporter 50 S1P 50 astemizole 50 ghrelin antagonist 50 tryptase 50 TLR antagonist 50 μg ml 50 somatostatin analogs 50 glatiramer acetate 50 nucleotide analog polymerase inhibitor 50 CLL SLL 50 Imatinib Mesylate 50 bazedoxifene selective estrogen receptor 50 Bone Morphogenetic Protein 50 Submits IND 50 metastatic malignant melanoma 50 peroxisomal 50 topoisomerase II 50 hTERT 50 secretory proteins 50 amino acid substitutions 50 Muscarinic 50 COPAXONE 50 dimerization 50 macroalbuminuria 50 Indomethacin 50 ß blockers 50 non nucleoside HCV 50 LHRH receptor positive 50 Novel Therapeutic 50 Anticalins ® 50 fibrogenesis 50 HOXB# 50 PEGylated interferon 50 Western blotting 50 CD# receptor 50 affinity purification 50 carboxylase 50 AutoVac TM 50 acyl CoA 50 HBV genotypes 50 adrenergic receptors 50 Systemic Lupus Erythematosus SLE 50 Transdermal Delivery 50 highly selective endothelin 50 Transferrin 50 ornithine 50 HER2 overexpression 50 Non Alcoholic Steatohepatitis 50 TNF receptors 50 tyrosine kinase inhibitors TKIs 50 covalently bound 50 Lupron Depot R 50 secretagogue 50 steroid sulfatase 50 CTGF 50 AST ALT 50 antithrombotic 50 triphosphate 50 epothilones 50 beta interferons 50 peptidomimetic 50 PON1 50 diabetic gastroparesis 50 hydroxylase 50 Anesth 50 Derived Factor 50 Valtropin 50 deacetylase 50 Inhibitor 50 serotonin receptor 50 ACC2 50 vinorelbine tartrate 50 mda 7 50 transcriptional regulation 50 interferon lambda 50 mitotic kinesin 50 FLT3 kinase 50 2DG 50 Glatiramer acetate 50 Dopaminergic 50 isozymes 50 Bruton tyrosine kinase 50 Cinacalcet HCl 50 vasoactive 50 glycoprotein GP IIb IIIa 50 aggrecan 50 Antisense Therapeutics 50 polycystin 1 50 Sp1 50 ODNs 50 TRPV4 50 ALK inhibitors 50 PsA 50 ABCG2 50 taxane derivative 50 Balaglitazone 50 basal cell carcinoma BCC 50 androgen receptor antagonist 50 CTEPH 49 GSTP1 49 cinacalcet 49 HBsAg 49 factor VIIa 49 prostaglandin synthesis 49 Histone H3 49 adrenergic agonists LABAs 49 matrix metalloproteinases 49 NTx 49 Illumina GoldenGate 49 endocannabinoid signaling 49 tubulin inhibitor 49 Initiates Clinical 49 iNOS 49 PPAR peroxisome proliferator activated 49 anaplastic lymphoma kinase ALK 49 beta tubulin 49 oligosaccharide 49 PC3 cells 49 lytic 49 activate AMPK 49 antiandrogens 49 SGS# 49 PDGF receptor 49 clomipramine 49 Actelion Pharmaceuticals Ltd 49 Transdrug R 49 Immunohistochemical staining 49 monophosphate 49 alpha1 antitrypsin deficiency 49 aspartyl 49 papillary RCC 49 protein tyrosine phosphatase 49 Neurobiological 49 Ala Ala 49 Synthase 49 RNase L 49 hydroxypropyl 49 ACEIs 49 #:#-# [031] 49 histone H3 49 transcriptional repressor 49 chemoresistant 49 oral renin inhibitor 49 glucose transporter 49 A2A receptor 49 natalizumab 49 ß1 49 #I [003] 49 somatostatin receptor 49 ALDH2 49 μM 49 panobinostat 49 upregulating 49 recurrent glioblastoma 49 HCV polymerase 49 ® C1 esterase 49 GPIIb IIIa 49 RNase 49 antithyroid 49 Tesmilifene 49 microsomal triglyceride transfer 49 inhaled AAT 49 Weinstock Guttman 49 Supplemental Figure 49 visilizumab 49 platelet activating 49 HuMax Inflam 49 immunoreactive 49 cytogenetic abnormalities 49 Technosphere ® 49 Rho GTPase 49 recombinant fusion 49 RTP #i 49 Rheoscience 49 ,#,# [002] 49 Pancreatic 49 CML CP 49 NKX#.# 49 pamidronate 49 Clinical Relevance 49 small molecule modulators 49 urothelial carcinoma 49 Aerosolized 49 mGluRs 49 Pharmacological 49 N acetyltransferase 49 covalently linked 49 L methionine 49 diol 49 pancreatic enzyme replacement 49 insulin aspart 49 histone deacetylase HDAC 49 vascular thrombosis 49 metabolite profiling 49 Tyrosine Kinase 49 MMP9 49 HER1 49 H2 antagonists 49 ghrelin agonist 49 tetramer 49 glucan 49 Biol 49 pelvic lymphadenectomy 49 MDACC 49 constitutively 49 squamous cell carcinoma SCC 49 bone morphogenetic proteins 49 ® interferon beta 49 dihydropyridine 49 antimitotic 49 Zinc Finger 49 Ad5FGF 4 49 HLA DRB1 * 49 MoxDuo ® 49 mutated K ras 49 bone morphogenetic protein 49 anticholinergic agents 49 M2 subunit 49 GCase 49 alemtuzumab Campath 49 orthotopic 49 CG# [003] 49 endonuclease 49 Activating mutations 49 pain palliation 49 IFN beta 49 HBeAg negative chronic hepatitis 49 CXCR4 antagonist 49 novel antifolate 49 inducible